Jason M. Walsh
Oprichter bij Provenance Biopharmaceuticals Corp.
Actieve functies van Jason M. Walsh
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Provenance Biopharmaceuticals Corp.
 Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Oprichter | 01-01-2008 | - |
| Corporate Officer/Principal | - | - | |
| Bioscience Network, Inc. | President | 26-10-2010 | - |
Loopbaan van Jason M. Walsh
Eerdere bekende functies van Jason M. Walsh
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | - | - |
Lexigen Pharmaceuticals Corp.
 Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Financieel Directeur/CFO | - | - |
Opleiding van Jason M. Walsh
| University of Massachusetts | Undergraduate Degree |
| Babson College | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Duitsland | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Founder | 1 |
| Director of Finance/CFO | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MERCK KGAA | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Provenance Biopharmaceuticals Corp.
Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Health Technology |
Lexigen Pharmaceuticals Corp.
Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Commercial Services |
| Bioscience Network, Inc. |
- Beurs
- Insiders
- Jason M. Walsh
- Ervaring
